Stockscreener 앱 받기
88.32
3.95%
-3.63
시간 외 거래:
88.32
전일 마감가:
$91.95
열려 있는:
$91.44
하루 거래량:
824.39K
Relative Volume:
0.70
시가총액:
$11.01B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-19.20
EPS:
-4.6
순현금흐름:
$-616.24M
1주 성능:
-1.47%
1개월 성능:
+7.89%
6개월 성능:
+11.95%
1년 성능:
+23.66%
1일 변동 폭
$88.21
$91.86
1주일 범위
$88.00
$93.77
52주 변동 폭
$58.10
$121.06
백스사이트 Stock (PCVX) Company Profile
명칭
Vaxcyte Inc
전화
650-837-0111
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
88.32 | 11.01B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
백스사이트 Stock (PCVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Goldman | Buy |
| 2023-12-07 | 개시 | Mizuho | Buy |
| 2023-04-18 | 개시 | TD Cowen | Outperform |
| 2023-01-03 | 재확인 | Needham | Buy |
| 2022-12-15 | 개시 | Guggenheim | Buy |
| 2022-11-17 | 개시 | BTIG Research | Buy |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-06-24 | 재개 | Jefferies | Buy |
| 2020-07-07 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 개시 | Needham | Buy |
모두보기
백스사이트 주식(PCVX)의 최신 뉴스
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference - The Manila Times
Vaccine Innovator Vaxcyte Takes Center Stage at Elite Guggenheim Biotech Conference - StockTitan
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - GlobeNewswire Inc.
(PCVX) Proactive Strategies - Stock Traders Daily
Andrew Guggenhime Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Cantor Fitzgerald Predicts Vaxcyte FY2025 Earnings - MarketBeat
Vaxcyte president and CFO sells shares worth $692,100 - MSN
Vaxcyte president and CFO sells shares worth $692,100 By Investing.com - Investing.com South Africa
CARGO Therapeutics, Inc. Enters into Sublease Agreement with Vaxcyte, Inc -July 08, 2024 at 04:18 pm EDT - Marketscreener.com
Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market - MSN
Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Insider Monkey
Vaxcyte (NASDAQ:PCVX) Trading Up 7.8%Should You Buy? - MarketBeat
Teri Loxam Sells 6,250 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Alexandria Announces Long-Term Lease at San Carlos Mega Campus - MSN
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Vaxcyte (NASDAQ:PCVX) Stock Price Up 7.8%Here's What Happened - MarketBeat
Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy (NASDAQ:PCVX) - Seeking Alpha
Leerink Partnrs Forecasts Vaxcyte FY2029 Earnings - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
Diversified Trust Co Acquires New Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock - Investing.com India
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock By Investing.com - Investing.com Canada
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - The Malaysian Reserve
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $145.71 - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 By Investing.com - Investing.com Australia
Jim Wassil Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Principal Financial Group Inc. - MarketBeat
Vaxcyte (NASDAQ:PCVX) Trading Down 5.8%Here's What Happened - MarketBeat
When (PCVX) Moves Investors should Listen - Stock Traders Daily
Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024? - MSN
10 Best Performing Biotech Stocks in 2024 - Insider Monkey
Vaxcyte stock supported by Goldman Sachs for addressing next-gen vaccine challenges - Investing.com Canada
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset - MSN
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ) - Seeking Alpha
Vaxcyte (NASDAQ:PCVX) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Vaxcyte's president and CFO sells $710,248 in stock transactions - Investing.com India
Vaxcyte's president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of Stock - MarketBeat
Vaxcyte’s president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Nigeria
백스사이트 (PCVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.95%
2.39%
자본화:
|
볼륨(24시간):